Foros de Conocimiento
medtronic PRODUCTOS
boston_scientific PRODUCTOS
TERUMO PRODUCTOS
Biotronik PRODUCTOS
Sirtex PRODUCTOS
Striker Neurovascular PRODUCTOS
BIOSENSORS PRODUCTOS

ABSTRACT


01 septiembre 2016

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY. Initial Experience with CT–Guided High-Dose-Rate Brachytherapy in the Multimodality Treatment of Neuroendocrine Tumor Liver Metastases

Alexander C. Schippers, MD, Federico Collettini, MD, Ingo G. Steffen, MD, Gero Wieners, MD, Timm Denecke, MD, Marianne Pavel, MD, Peter Wust, MD, Bernhard Gebauer, MD

Purpose: To evaluate efficacy of computed tomography (CT)–guided high-dose-rate brachytherapy (HDRBT) of neuroendocrine liver metastases (NELM) with the goal of local tumor control (LTC).

01 septiembre 2016

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY. Single- versus Triple-Drug Chemoembolization for Hepatocellular Carcinoma: Comparing Outcomes by Toxicity, Imaging Response, and Survival

Samdeep K. Mouli, MD, Ryan Hickey, MD, Bartley Thornburg, MD, Kent T. Sato, MD, Kush Desai, MD, Ahmed Gabr, MD, Joseph R. Kallini, MD, Halla Niemeri, MD, Sheetal Kircher, MD, Mary F. Mulcahy, MD, Al B. Benson III, MD, Ramona Gupta, MD, Riad Salem, MD, MBA, Robert J. Lewandowski, MD

Purpose: To determine the efficacy of single- versus triple-drug chemoembolization for the treatment of hepatocellular carcinoma, as measured by toxicity, tumor response, time to progression (TTP), and overall survival (OS).

01 septiembre 2016

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY. A Modified Model for Assessment for Retreatment with Transarterial Chemoembolization in Chinese Hepatocellular Carcinoma Patients

Li Chen, MM, Cai-Fang Ni, MD, Shi-Xi Chen, MD, Jian-Min Cao, MD, Hai-Dong Zhu, MD, Jin-He Guo, MD, Guang-Yu Zhu, MM, Bin-Yan Zhong, MM, Wei Ding, MM, Shi-Cheng He, MD, Gang Deng, MD, Gao-Jun Teng, MD

Purpose: To develop a modified assessment for retreatment with transarterial chemoembolization (mART) score that may be more suitable for Chinese patients with hepatocellular carcinoma (HCC).

01 septiembre 2016

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY. Yttrium-90 Radioembolization of Advanced, Unresectable Breast Cancer Liver Metastases—A Single-Center Experience

Claus Christian Pieper, MD, Carsten Meyer, MD, Kai E. Wilhelm, MD, Wolfgang Block, PhD, Jennifer Nadal, MSc, Hojjat Ahmadzadehfar, MD, Winfried Albert Willinek, MD, Hans Heinz Schild, MD

Purpose: To determine value of transarterial radioembolization (TARE) for palliative treatment of unresectable liver-dominant breast metastases (LdBM) and to determine prognostic parameters.

01 septiembre 2016

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY. Yttrium-90 Radioembolization for Breast Cancer Liver Metastases

Andrew C. Gordon, BA, Riad Salem, MD, MBA, Robert J. Lewandowski, MD

The National Comprehensive Cancer Network Breast Cancer Panel updated its clinical practice guidelines in May 2016 to reflect several emerging trends in the treatment of metastatic breast cancer (MBC). First, the panel recommends allocating systemic therapy based on the location and biology of disease. Specifically, the presence or absence of bone metastases and the patient’s hormonal estrogen receptor and progesterone receptor and HER2 status are used to guide treatment with biologic agents, endocrine therapy, or cytotoxic chemotherapy.

01 septiembre 2016

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY. Intravoxel Incoherent Motion Diffusion-Weighted MR Imaging for Prediction of Early Arterial Blood Flow Stasis in Radioembolization of Breast Cancer Liver Metastases

Claus Christian Pieper, MD, Winfried Albert Willinek, MD, Carsten Meyer, MD, Hojjat Ahmadzadehfar, MD, Guido Matthias Kukuk, MD, Alois Martin Sprinkart, MSc, Wolfgang Block, PhD, Hans Heinz Schild, MD, Petra Mürtz, PhD

Purpose: To retrospectively evaluate predictive value of intravoxel incoherent motion (IVIM) diffusion-weighted imaging (DWI) for early arterial blood flow stasis during transarterial radioembolization (TARE) of liver dominant breast metastases (LdBM).

01 septiembre 2016

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY. Angiogenic Response following Radioembolization: Results from a Randomized Pilot Study of Yttrium-90 with or without Sorafenib

Robert J. Lewandowski, MD, Jessica M. Andreoli, MD, Ryan Hickey, MD, Joseph R. Kallini, MD, Ahmed Gabr, MD, Talia Baker, MD, Sheetal Kircher, MD, Riad Salem, MD, MBA, Laura Kulik, MD

Purpose: To compare the regulation of serum angiogenic factors in patients with unresectable early hepatocellular carcinoma (HCC) treated with yttrium-90 (90Y) radioembolization alone vs with sorafenib.

01 septiembre 2016

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY. Long-Term Survival after Radiofrequency Ablation of Lung Oligometastases from Five Types of Primary Lesions: A Retrospective Evaluation

Kenichi Omae, MD, Takao Hiraki, MD, Hideo Gobara, MD, Toshihiro Iguchi, MD, Hiroyasu Fujiwara, MD, Yusuke Matsui, MD, Shinichi Toyooka, MD, Takeshi Nagasaka, MD, Susumu Kanazawa, MD

Purpose: To conduct a retrospective evaluation of long-term survival after radiofrequency (RF) ablation for lung oligometastases from 5 types of primary lesions.

01 septiembre 2016

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY. Percutaneous Cryoablation for the Treatment of Primary and Metastatic Lung Tumors: Identification of Risk Factors for Recurrence and Major Complications

Joseph L. McDevitt, MD, MBA, Samdeep K. Mouli, MD, MS, Albert A. Nemcek, Jr, MD, Robert J. Lewandowski, MD, Riad Salem, MD, MBA, Kent T. Sato, MD

Purpose: To identify risk factors for local recurrence and major complications associated with percutaneous cryoablation of lung tumors.

01 septiembre 2016

AMERICAN JOURNAL OF ROENTGENOLOGY. Quantitative Measurements of Enhancement on Preprocedure Triphasic CT Can Predict Response of Colorectal Liver Metastases to Radioembolization

F. Edward Boas, Lynn A. Brody, Joseph P. Erinjeri, Hooman Yarmohammadi, Waleed Shady, Sirish Kishore and Constantinos T. Sofocleous

OBJECTIVE. Colorectal liver metastases (CLM) have a variable response to radioembolization. This may be due at least partly to differences in tumor arterial perfusion. The present study examines whether quantitative measurements of enhancement on preprocedure triphasic CT can be used to predict the response of CLM to radioembolization.

01 septiembre 2016

AMERICAN JOURNAL OF ROENTGENOLOGY. Surrogate Imaging Biomarkers of Response of Colorectal Liver Metastases After Salvage Radioembolization Using 90Y-Loaded Resin Microspheres

Waleed Shady, Vlasios S. Sotirchos, Richard K. Do, Neeta Pandit-Taskar, Jorge A. Carrasquillo, Mithat Gonen and Constantinos T. Sofocleous

OBJECTIVE. The purpose of the present study is to evaluate Response Evaluation Criteria in Solid Tumors (RECIST) version 1.1, tumor attenuation criteria, Choi criteria, and European Organization for Research and Treatment of Cancer (EORTC) PET criteria as measures of response and subsequent predictors of liver progression-free survival (PFS) after radioembolization (RE) of colorectal liver metastases (CLM). The study also assesses interobserver variability for measuring tumor attenuation using a single 2D ROI on a simple PACS workstation.

01 septiembre 2016

AMERICAN JOURNAL OF ROENTGENOLOGY. Outcomes of Preoperative MRI-Guided Needle Localization of Nonpalpable Mammographically Occult Breast Lesions

Yiming Gao, Neeti R. Bagadiya, Meghan L. Jardon, Samantha L. Heller, Amy N. Melsaether, Hildegard B. Toth and Linda Moy

OBJECTIVE. MRI-guided needle localization allows access to MRI-detected mammographically occult breast lesions that are not amenable to MRI-guided biopsy. The purpose of this study was to examine the safety and outcomes of MRI-guided needle localization.

Utilizamos cookies propias para el correcto funcionamiento del sitio web y mejorar nuestros servicios. Pulse el botón Aceptar todas para aceptar su uso. Puede cambiar la configuración u obtener más información en nuestra Política de cookies o pulsando Modificar configuración.